2,999
Views
6
CrossRef citations to date
0
Altmetric
Research Article

HIFU as an alternative modality for patients with uterine fibroids who require fertility-sparing treatment

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, & ORCID Icon show all
Article: 2155077 | Received 24 Oct 2022, Accepted 29 Nov 2022, Published online: 05 Jan 2023
 

Abstract

Objectives

To compare pregnancy outcomes after high-intensity focused ultrasound ablation (HIFU), myomectomy and uterine artery embolization (UAE) for fertility-sparing patients with uterine fibroids and to investigate the possible mechanism of improving pregnancy by HIFU.

Materials and methods

A meta-analysis of 54 studies containing 12,367 patients was conducted to compare the pregnancy outcomes of three fertility-sparing therapies. And a retrospective self-control study of 26 patients with uterine fibroids from May 2019 to December 2020 was performed to assess the blood flow impedance of bilateral uterine arteries before and after HIFU.

Results

In the analysis by treatment option, the pregnancy rate after myomectomy was 0.43 (95% CI 0.36–0.49), which was higher than 0.18 (95% CI 0.10–0.26) after HIFU, the latter was significantly higher than that after UAE (ratio 0.08, 95% CI 0.06–0.10). The miscarriage rate after HIFU was 0.08 (95% CI 0.04–0.12), which was similar to 0.15 (95% CI 0.09–0.21) after myomectomy and also similar to 0.16 after UAE (95% CI 0.01–0.30). In the subgroup analysis, women who received ultrasound guided HIFU (USgHIFU) were more likely to have ideal pregnancy outcomes than that after magnetic resonance imaging-guided HIFU. The pulsatility index and resistance index on the right side were significantly higher 3 months after HIFU than before (1.637 ± 0.435 vs. 1.845 ± 0.469; p = 0.033; 0.729 ± 0.141 vs. 0.784 ± 0.081, p = 0.039).

Conclusions

HIFU, especially USgHIFU, may be an alternative fertility-sparing modality for patients with uterine fibroids over 40 years old. HIFU may contribute to improving pregnancy rates by elevating uterine blood flow impedance.

Disclosure statement

No potential conflicts of interest are reported by the author(s).

Data availability statement

The authors confirm that the data supporting the findings of this study are available within the article.